首页> 外文期刊>Cancer Management and Research >The prognostic value of preoperative controlling nutritional status score in non-metastatic renal cell carcinoma treated with surgery: a retrospective single-institution study
【24h】

The prognostic value of preoperative controlling nutritional status score in non-metastatic renal cell carcinoma treated with surgery: a retrospective single-institution study

机译:术前控制性营养状况评分在非转移性肾细胞癌手术治疗中的预后价值:一项回顾性单机构研究

获取原文
           

摘要

Purpose: This study aimed to investigate the significance of the controlling nutritional status (CONUT) score as a predictor for survival outcomes for non-metastatic renal cell carcinoma (RCC) patients. Methods: We retrospectively reviewed 325 patients who received surgical treatment for renal cell carcinoma between 2010 and 2012 at Peking University First Hospital. Patients were divided into two groups according to the optimal cut-off value of CONUT score. Kaplan–Meier method and log-rank test were used for survival analysis according to different CONUT groups. Cox proportional hazards regression models were performed to assess the prognostic value of clinicopathological parameters for overall survival (OS), cancer-specific survival (CSS) and disease-free survival (DFS) respectively. Results: The optimal cut-off value of CONUT score was 3. High CONUT score significantly correlated to higher tumor grade ( P 0.001), later pathological T stage ( P 0.001) and tumor necrosis ( P 0.001). Patients with higher CONUT score had worse OS (HR 5.34, 95% CI 2.29–12.46, P 0.001), CSS (HR 5.51, 95% CI 2.12–14.33, P 0.001) and DFS (HR 4.23, 95% CI 2.16–8.29, P 0.001). In multivariable analysis, high CONUT score was an independent risk factor for OS, CSS and DFS (OS: HR=3.36, 95% CI 1.73–6.56, P 0.001; CSS: HR=3.34, 95% CI 1.59–6.98, P =0.001; DFS: HR=1.85, ]95% CI 1.07–3.21, P =0.029) Conclusion: Preoperative CONUT score was an independent prognostic factor for OS, CSS and DFS in non-metastatic RCC patients treated with surgery.
机译:目的:本研究旨在探讨控制营养状况(CONUT)评分作为非转移性肾细胞癌(RCC)患者生存结果的预测指标的意义。方法:我们回顾性分析了2010年至2012年间在北京大学第一医院接受手术治疗的325例肾细胞癌患者。根据CONUT评分的最佳临界值将患者分为两组。根据不同的CONUT组,使用Kaplan-Meier方法和对数秩检验进行生存分析。进行Cox比例风险回归模型以评估临床病理参数分别对总体生存期(OS),癌症特异性生存期(CSS)和无病生存期(DFS)的预后价值。结果:CONUT评分的最佳分界值为3。高CONUT评分与较高的肿瘤分级(P <0.001),晚期病理T分期(P <0.001)和肿瘤坏死(P <0.001)显着相关。 CONUT评分较高的患者的OS(HR 5.34,95%CI 2.29–12.46,P <0.001),CSS(HR 5.51,95%CI 2.12–14.33,P <0.001)和DFS(HR 4.23,95%CI 2.16)较差。 –8.29,P <0.001)。在多变量分析中,高CONUT评分是OS,CSS和DFS的独立危险因素(OS:HR = 3.36,95%CI 1.73–6.56,P <0.001; CSS:HR = 3.34,95%CI 1.59-6.98,P = 0.001; DFS:HR = 1.85,] 95%CI 1.07–3.21,P = 0.029)结论:术前CONUT评分是接受手术治疗的非转移性RCC患者OS,CSS和DFS的独立预后因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号